- Summary Information
|
Company Name |
PHARMA LINKS |
Principal Name 1 |
Mr. Pranay |
|
Status |
Small concern |
Principal Name 2 |
-- |
|
Street Address |
304, Deora Commercial Centre, Orlem One Way Road, Malad (West), Mumbai
– 400 006, Maharashtra, India. |
||
|
Established Date |
1998 |
SIC Code |
-- |
|
Telephone# |
91-22-28620657 |
Business Style 1 |
Manufacturer |
|
Fax # |
91-22-28620657 |
Business Style 2 |
-- |
|
Homepage |
Product Name 1 |
Pharmaceutical Bottles |
|
|
# of employees |
100 |
Product Name 2 |
Raw materials |
|
Paid up capital |
-- |
Product Name 3 |
Surgical Equipment |
|
Shareholders |
-- |
Banking |
|
|
Public Limited Corp. |
NO |
Business Period |
10 Years |
|
IPO |
NO |
International Ins. |
- |
|
Public Enterprise |
NO |
Rating |
Ca |
|
Related Company |
|||
|
Relation -- |
Country -- |
Company Name |
-- |
|
Note |
- |
||
- Summary Financial Statement
|
Balance Sheet as of |
31.03.2008 |
(Unit: Indian Rs.) |
|
|
Assets |
Liabilities |
||
|
Current Assets |
-- |
Current Liabilities |
-- |
|
Inventories |
-- |
Long-term Liabilities |
-- |
|
Fixed Assets |
-- |
Other Liabilities |
-- |
|
Deferred Assets |
-- |
Total Liabilities |
-- |
|
Invest& other Assets |
-- |
Retained Earnings |
-- |
|
|
|
Net Worth |
-- |
|
Total Assets |
-- |
Total Liab. & Equity |
-- |
|
Total Assets (Previous Year) |
-- |
|
|
|
P/L Statement as of |
31.03.2008 |
(Unit: Indian Rs.) |
|
|
Sales |
-- |
Net Profit |
-- |
|
Sales(Previous yr) |
-- |
Net Profit(Prev.yr) |
-- |
MIRA
INFORM REPORT
|
Report Date : |
18.12.2008 |
IDENTIFICATION
DETAILS
|
Name : |
PHARMA LINKS |
|
|
|
|
Registered Office : |
304, Deora Commercial Centre, Orlem One Way Road, Malad (West), Mumbai
– 400 006, Maharashtra. |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2008 |
|
|
|
|
Year of Establishment : |
1998 |
|
|
|
|
Legal Form : |
Sole Proprietor Concern |
|
|
|
|
Line of Business : |
Manufacturer of Pharmaceutical Bottles, Raw Materials and Surgical
Equipments. |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ca |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
Status : |
Small Concern |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject seems to be a relatively small concern in its field. The management
declined to part with any details. No further details or payment could be
made available. The concern can be considered for any business dealings on safe and
secured terms only. |
INFORMATION
DECLINED BY
|
Name : |
Mr. Pranay Nikam |
|
Designation : |
Proprietor |
|
Contact No.: |
91-987080818 |
|
Date : |
18.12.2008 |
LOCATIONS
|
Registered Office : |
304, Deora Commercial Centre, Orlem One Way Road, Malad (West), Mumbai
– 400 006, Maharashtra, India |
|
Tel. No.: |
91-22-28620657 |
|
Mobile No.: |
91-9870808181 (Mr. Pranay) |
|
Fax No.: |
91-22-28620657 |
|
E-Mail : |
|
|
Website : |
PROPRIETOR
|
Name : |
Mr. Pranay Nikam |
|
Designation : |
Proprietor |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of Pharmaceutical Bottles, Raw Materials and Surgical
Equipments |
GENERAL
INFORMATION
|
No. of Employees : |
Around 100 |
|
|
|
|
Bankers : |
Not Available |
|
|
|
|
Facilities : |
-- |
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
|
|
|
Associates/Subsidiaries : |
NIL |
CAPITAL STRUCTURE
NOT AVAILABLE
FINANCIAL DATA
[all figures are in Rupees Millions]
|
Particulars |
|
|
31.03.2008 |
|
Sales Turnover (Estimated) |
|
|
10.000 |
LOCAL AGENCY
FURTHER INFORMATION
TRADE REFERENCES
Smilax Laboratories Limited - Hyderabad
AS PER WEBSITE:
PROFILE:
Subject, an export arm of Smilax Laboratories where the main group
company is into a number of segments ranging from waste management to
infrastructure development.The pharmaceutical export wing is managed and looked
after by PHARMA Links from India as well as from its Dubai office, wherein they
have built partnerpartnerships with foreign companies for the supply of API’s
and pellets.
Concern research and development team consists of over 55 individuals who are
dedicated towards providing technological breakthrough and the best yielding
processes whose merits are rightly passed over to concern elite customer base
worldwide. They are coming up with yet another state of the art cGMP
manufacturing facility in South India wherein a variety of bulk drugs including
sustained release drugs and DC grade materials would be manufactured. They have
Open Part DMF (in CTD format) for most of concern products, a list of which is
attached herewith for your ready reference.
Over the years putting systems and processes into practice, they
augmented they bequest and reputation in many countries through Customer
Service, Logistics Support, Technical Support and Regulatory
CMT REPORT (Corruption,
Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government official
or a family member or close business associate of a Government official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.47.33 |
|
UK Pound |
1 |
Rs.73.92 |
|
Euro |
1 |
Rs.66.69 |
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|